Medistim ASA (OSL:MEDI)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 4.75 billion. The enterprise value is 4.61 billion.

Market Cap	4.75B
Enterprise Value	4.61B

Important Dates

The next estimated earnings date is Thursday, April 9, 2026.

Earnings Date	Apr 9, 2026
Ex-Dividend Date	May 9, 2025

Share Statistics

Medistim ASA has 18.27 million shares outstanding.

Current Share Class	18.27M
Shares Outstanding	18.27M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.93%
Owned by Institutions (%)	86.08%
Float	12.61M

Valuation Ratios

The trailing PE ratio is 33.38 and the forward PE ratio is 30.67.

PE Ratio	33.38
Forward PE	30.67
PS Ratio	7.17
PB Ratio	11.35
P/TBV Ratio	14.02
P/FCF Ratio	25.69
P/OCF Ratio	24.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.80, with an EV/FCF ratio of 24.95.

EV / Earnings	32.40
EV / Sales	6.97
EV / EBITDA	22.80
EV / EBIT	25.68
EV / FCF	24.95

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.05.

Current Ratio	3.33
Quick Ratio	2.03
Debt / Equity	0.05
Debt / EBITDA	0.11
Debt / FCF	0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 34.58% and return on invested capital (ROIC) is 26.35%.

Return on Equity (ROE)	34.58%
Return on Assets (ROA)	21.07%
Return on Invested Capital (ROIC)	26.35%
Return on Capital Employed (ROCE)	40.19%
Revenue Per Employee	4.30M
Profits Per Employee	924,825
Employee Count	154
Asset Turnover	1.24
Inventory Turnover	0.77

Taxes

In the past 12 months, Medistim ASA has paid 44.88 million in taxes.

Income Tax	44.88M
Effective Tax Rate	23.96%

Stock Price Statistics

The stock price has increased by +52.94% in the last 52 weeks. The beta is 1.04, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+52.94%
50-Day Moving Average	244.36
200-Day Moving Average	201.27
Relative Strength Index (RSI)	67.28
Average Volume (20 Days)	37,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 662.18 million and earned 142.42 million in profits. Earnings per share was 7.79.

Revenue	662.18M
Gross Profit	536.55M
Operating Income	179.72M
Pretax Income	187.30M
Net Income	142.42M
EBITDA	193.62M
EBIT	179.72M
Earnings Per Share (EPS)	7.79

Balance Sheet

The company has 157.66 million in cash and 21.30 million in debt, giving a net cash position of 136.36 million or 7.46 per share.

Cash & Cash Equivalents	157.66M
Total Debt	21.30M
Net Cash	136.36M
Net Cash Per Share	7.46
Equity (Book Value)	418.60M
Book Value Per Share	22.91
Working Capital	298.33M

Cash Flow

In the last 12 months, operating cash flow was 191.02 million and capital expenditures -6.07 million, giving a free cash flow of 184.95 million.

Operating Cash Flow	191.02M
Capital Expenditures	-6.07M
Free Cash Flow	184.95M
FCF Per Share	10.12

Margins

Gross margin is 81.03%, with operating and profit margins of 27.14% and 21.51%.

Gross Margin	81.03%
Operating Margin	27.14%
Pretax Margin	28.29%
Profit Margin	21.51%
EBITDA Margin	29.24%
EBIT Margin	27.14%
FCF Margin	27.93%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 2.31%.

Dividend Per Share	6.00
Dividend Yield	2.31%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	n/a
Payout Ratio	76.86%
Buyback Yield	n/a
Shareholder Yield	2.31%
Earnings Yield	3.00%
FCF Yield	3.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6